|

Hetrombopag Clinical Trials

2 actively recruiting trials

No change since May 2026

Pipeline

Phase 2: 1

Top Sponsors

  • Changhai Hospital1
  • Beijing Children's Hospital1

Indications

  • Cancer2
  • Chemotherapy-induced Thrombocytopenia (CIT) in Patients With Gastrointestinal Tumors1
  • Autologous Hematopoietic Stem Cell Transplantation1
  • Delayed Platelet Engraftment1
  • Neuroblastoma1

Other2 trials

Efficacy and Safety of Hetrombopag in Preventing Chemotherapy-induced Thrombocytopenia in Gastrointestinal Tumors
Phase 2
Hetrombopag in Promoting Platelet Engraftment After Auto-HSCT in Children With Neuroblastoma
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.